PORTLAND, Ore., March 21 /PRNewswire-FirstCall/ -- Bioject Medical Technologies Inc., , a leading developer of needle-free drug delivery systems, announced today that the Company will report its financial results for the fourth quarter ended December 31, 2006 on Tuesday, March 27, 2007, after the close of the financial markets. Management will conduct a conference call on Wednesday, March 28, 2007 at 10:00 a.m. Eastern Time to review the results for the quarter and the year. Jerald Cobbs, Chairman, Interim CEO and President, Dr. Rick Stout, EVP and Chief Medical Officer and Chris Farrell, Vice President of Finance, will be hosting the call.
Live audio of the conference call will be simultaneously broadcast over the Internet and will be available to investors, members of the news media and the general public. To participate in the call via telephone, please dial 1-877-407-8037, or to access the call live over the Internet, visit Bioject’s website at www.bioject.com and click on the Investor Relations section, then on the event icon. A conference call replay will also be available until April 4, 2007. To listen to the replay, please dial 1-877-660-6853 replay account number 7303, identification number 235841.
Bioject Medical Technologies Inc., based in Portland, Oregon, is an innovative developer and manufacturer of needle-free drug delivery systems. Needle-free injection works by forcing medication at high speed through a tiny orifice held against the skin. This creates a fine stream of high-pressure fluid penetrating the skin and depositing medication in the tissue beneath. The Company is focused on developing mutually beneficial agreements with leading pharmaceutical, biotechnology, and veterinary companies.
For more information about Bioject, visit: www.bioject.com.
Bioject Medical Technologies Inc.
CONTACT: Jerald S. Cobbs, Chairman, Interim CEO and President,+1-503-692-8001 ext. 4161, or Chris Farrell, Vice President of Finance,+1-503-692-8001, ext. 4132, both of Bioject Medical Technologies Inc
Web site: http://www.bioject.com//
